Sequential gene targeting to make chimeric tumor models with de novo chromosomal abnormalities.
The discovery of chromosomal translocations in leukemia/lymphoma and sarcomas presaged a widespread discovery in epithelial tumors. With the advent of new-generation whole-genome sequencing, many consistent chromosomal abnormalities have been described together with putative driver and passenger mutations. The multiple genetic changes required in mouse models to assess the interrelationship of abnormalities and other mutations are severe limitations. Here, we show that sequential gene targeti...Expand abstract
- Publisher copy:
- American Association for Cancer Research Inc.
- Cancer research
- Publication date:
- Source identifiers:
- Local pid:
- Copyright date: